Fundraising Fox
Philogen
Not specified, CH · 1 known investors
Find your way into Philogen
Sign up to find every way you can get introduced to Philogen
- Your email: who you already know at Philogen, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Philogen team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.
Investors · 1
Funding
SEC filings, press & company announcements$70M disclosed across 1 round · 2019
- $70MraisedMay 2019 · 5 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Philogen do?
- Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.
- Who are Philogen's investors?
- Philogen's investors include NovaCapital.
- How much funding has Philogen raised?
- Philogen has disclosed $70M raised across 1 round.
- Where is Philogen headquartered?
- Philogen is headquartered in Not specified, CH.